IR Information

Latest IR Information

Latest Financial Results

Financial Results for 1st Quarter of Fiscal Year 2021(Announced on August 4, 2021)

Financial Statements

Results Briefing(August 4, 2021)

Q&A(Summary)

IR Calendar IR Documents Archive

IR News

2021/10/14
Notice of passing eligibility examination as active pharmaceutical ingredient (API) producing facility by US Food and Drug Administration (FDA)
2021/08/04
Consolidated Financial Report for 1st Quarter of Fiscal Year 2021(April 1, 2021 through June 30, 2021)
2021/08/04
Supplemental Documents for 1st Quarter of Fiscal Year 2021
2021/06/17
Partial amendment of "NOTICE OF THE 106th ORDINARY GENERAL SHAREHOLDERS' MEETING"
2021/06/16
(Updated) Partial revisions of "Consolidated Financial Results for the Year ended March 31, 2021" and "Supplemental Documents for FY2020"

IR News Press Release

Management Policy

Explanation of our management system, from the President to our shareholders.

For individual shareholders

Information of interest to individual shareholders including financial highlights

Shareholder and Stock Information

Useful information regarding stocks and various procedures for our shareholders.

Financial Information and Results

Nissui's performance and main financial indicators can be seen in graphs and numerical data.

IR Library

Shareholder updates and financial documents can be viewed here.

IR Library

IR Related Links

Corporate Information

You need the latest Adobe Reader to read. You can download that software (for free) from the Adobe web site.

The information on this site pertaining to Nippon Suisan Kaisha, Ltd.'s current planning, strategies and convictions, etc. not based on historical events is a forecast of future performance that includes risk and undetermined factors. Please be advised that, due to various factors, actual performance may differ from the forecast.

NISSUI Like!

Nissui: for Human Health and Sparkling Seas